SCHEMBL13774580

SCHEMBL13774580

O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(SC(F)(F)C(F)F)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
ATM Q13315 1/20 0.46
TLR7 Q9NYK1 1/20 0.45
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
PKM P14618 1/20 0.41
IL2 P60568 1/20 0.40
TRPA1 O75762 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
GAA P10253 5/20 0.39
PPIA P62937 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
THRB P10828 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10798511 0.81 ATM (0.49) MAPTMEN1KMT2AUSP2ALOX15
Hexaflumuron SCHEMBL26793 0.81 MEN1 (0.59) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL10360662 0.81 KMT2A (0.56) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL10505684 0.81 MEN1 (0.61) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL4149967 0.80 MAPT (0.39) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL8840302 0.79 MEN1 (0.65) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL8840271 0.79 MEN1 (0.69) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL29232816 0.79 MEN1 (0.56) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL7586386 0.78 MEN1 (0.53) MAPTMEN1KMT2AUSP2ALOX15
SCHEMBL8660069 0.78 MEN1 (0.60) MAPTMEN1KMT2AUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MAPT 4585/4885MEN1 1863/4885KMT2A 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.